- Home
- OMIC vs BRNS Comparison
OMIC vs BRNS Comparison
Compare OMIC & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMIC
- BRNS
- Stock Information
- Founded
- OMIC 2016
- BRNS 2016
- Country
- OMIC United States
- BRNS United Kingdom
- Employees
- OMIC N/A
- BRNS N/A
- Industry
- OMIC Medical/Dental Instruments
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- OMIC Health Care
- BRNS Health Care
- Exchange
- OMIC Nasdaq
- BRNS Nasdaq
- Market Cap
- OMIC 50.4M
- BRNS 43.8M
- IPO Year
- OMIC 2021
- BRNS 2021
- Fundamental
- Price
- OMIC $20.01
- BRNS $1.00
- Analyst Decision
- OMIC Hold
- BRNS Strong Buy
- Analyst Count
- OMIC 2
- BRNS 2
- Target Price
- OMIC $10.75
- BRNS $3.00
- AVG Volume (30 Days)
- OMIC 7.8K
- BRNS 43.4K
- Earning Date
- OMIC 03-17-2025
- BRNS 03-19-2025
- Dividend Yield
- OMIC N/A
- BRNS N/A
- EPS Growth
- OMIC N/A
- BRNS N/A
- EPS
- OMIC N/A
- BRNS N/A
- Revenue
- OMIC $2,667,000.00
- BRNS $14,969,000.00
- Revenue This Year
- OMIC $0.82
- BRNS $1,803.87
- Revenue Next Year
- OMIC $252.64
- BRNS N/A
- P/E Ratio
- OMIC N/A
- BRNS N/A
- Revenue Growth
- OMIC 2.77
- BRNS 106.21
- 52 Week Low
- OMIC $5.34
- BRNS $0.80
- 52 Week High
- OMIC $23.41
- BRNS $4.16
- Technical
- Relative Strength Index (RSI)
- OMIC 56.74
- BRNS 46.05
- Support Level
- OMIC $19.82
- BRNS $0.96
- Resistance Level
- OMIC $20.27
- BRNS $1.15
- Average True Range (ATR)
- OMIC 0.14
- BRNS 0.12
- MACD
- OMIC 0.01
- BRNS 0.00
- Stochastic Oscillator
- OMIC 44.68
- BRNS 16.67
About OMIC Singular Genomics Systems Inc.
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.